Advancements in AI-driven diagnostics could transform cardiology, enabling autonomous interpretation of up to 80% of cardiac imaging within a decade. David Ouyang, MD, discusses overcoming barriers to running…
NEW YORK (Reuters Health) – In elderly heart failure patients with ejection fractions of 35% or less, implantable cardioverter defibrillators (ICD) can significantly improve long-term survival, according to…
NEW YORK (Reuters Health) – In patients with asymptomatic carotid stenosis (ACS), microemboli and cardiovascular events can be markedly reduced by aggressive medical therapy, Canadian research shows. This…
NEW YORK (Reuters Health) – In diabetic patients, sirolimus-eluting stents reduce the risk for coronary artery restenosis compared with paclitaxel-eluting stents, a meta-analysis shows. Because the relative efficacy…
NEW YORK (Reuters Health) – As the number of prescribed antithrombotic drugs after a first myocardial infarction increases, so does the risk of hospitalization for bleeding, according to…
NEW YORK (Reuters Health) – The use of undersized drug-eluting stents for saphenous vein graft lesions may reduce the long-term incidence of emboli and enzyme elevations without increasing…
NEW YORK (Reuters Health) – In type 2 diabetics with multiple comorbidities, tight glycemic control does not provide the same cardiovascular benefits that it does in diabetics with…
NEW YORK (Reuters Health) – New research shows that antidiabetes agents are not equal when it comes to cardiovascular risks and mortality. According to a report in the…
NEW YORK (Reuters Health) – Elevated C-reactive protein (CRP) levels are linked with an increased risk of stent thrombosis and cardiovascular events in patients with drug-eluting stents, say…
NEW YORK (Reuters Health) – The ratio of triglycerides to HDL cholesterol (TG/HDL) predicts first coronary events in men regardless of body-mass index, say researchers in the November…
NEW YORK (Reuters Health) – Intensive statin therapy is more effective than standard doses in reducing the risk of major adverse events after angioplasty for acute coronary syndromes…
